Evidence map›Paper›PMID 27512067›Full record

ArticleJournal of virology2016

Activation of the Chicken Anemia Virus Apoptin Protein by Chk1/2 Phosphorylation Is Required for Apoptotic Activity and Efficient Viral Replication.

Thomas J Kucharski, Timothy F Ng, David M Sharon, Pedram Navid-Azarbaijani, Mahvash Tavassoli, Jose G Teodoro

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Gyrovirus: current status and challenge.Frontiers in microbiology · 2024
    Review
  4. Article
  5. Review
  6. The Role of Apoptin in Chicken Anemia Virus Replication.Pathogens (Basel, Switzerland) · 2020
    Review
  7. Review
  8. Apoptosis Triggered by ORF3 Proteins of theFrontiers in cellular and infection microbiology · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Thomas J KucharskiGoodman Cancer Research Centre, McGill University, Montréal, QC, Canada Department of Biochemistry, McGill University, Montréal, QC, Canada.
Timothy F NgDepartment of Microbiology and Immunology, McGill University, Montréal, QC, Canada.
David M SharonGoodman Cancer Research Centre, McGill University, Montréal, QC, Canada Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.
Pedram Navid-AzarbaijaniDepartment of Microbiology and Immunology, McGill University, Montréal, QC, Canada.
Mahvash TavassoliDepartment of Molecular Oncology, King's College London, London, UK.
Jose G TeodoroGoodman Cancer Research Centre, McGill University, Montréal, QC, Canada Department of Biochemistry, McGill University, Montréal, QC, Canada Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada jose.teodoro@mcgill.ca.ORCID 0000-0002-3713-6839
McGill University Health Centre · CAMcGill University · CAKing's College London · GB

Funding

CIHR MOP-179122
6 · The paper itself

Abstract

unlabelledChicken anemia virus (CAV) is a single-stranded circular DNA virus that carries 3 genes, the most studied of which is the gene encoding VP3, also known as apoptin. This protein has been demonstrated to specifically kill transformed cells while leaving normal cells unharmed in a manner that is independent of p53 status. Although the mechanistic basis for this differential activity is unclear, it is evident that the subcellular localization of the protein is important for the difference. In normal cells, apoptin exists in filamentous networks in the cytoplasm, whereas in transformed cells, apoptin is present in the nucleus and appears as distinct foci. We have previously demonstrated that DNA damage signaling through the ataxia telangiectasia mutated (ATM) pathway induces the translocation of apoptin from the cytoplasm to the nucleus, where it induces apoptosis. We found that apoptin contains four checkpoint kinase consensus sites and that mutation of either threonine 56 or 61 to alanine restricts apoptin to the cytoplasm. Furthermore, treatment of tumor cells expressing apoptin with inhibitors of checkpoint kinase 1 (Chk1) and Chk2 causes apoptin to localize to the cytoplasm. Importantly, silencing of Chk2 rescues cancer cells from the cytotoxic effects of apoptin. Finally, treatment of virus-producing cells with Chk inhibitor protects them from virus-mediated toxicity and reduces the titer of progeny virus. Taken together, our results indicate that apoptin is a sensor of DNA damage signaling through the ATM-Chk2 pathway, which induces it to migrate to the nucleus during viral replication. IMPORTANCE: The chicken anemia virus (CAV) protein apoptin is known to induce tumor cell-specific death when expressed. Therefore, understanding its regulation and mechanism of action could provide new insights into tumor cell biology. We have determined that checkpoint kinase 1 and 2 signaling is important for apoptin regulation and is a likely feature of both tumor cells and host cells producing virus progeny. Inhibition of checkpoint signaling prevents apoptin toxicity in tumor cells and attenuates CAV replication, suggesting it may be a future target for antiviral therapy.

Indexed as

ApoptosisCapsid ProteinsCell Line, TumorCell NucleusCheckpoint Kinase 1Checkpoint Kinase 2Chicken anemia virusCytoplasmDNA DamageHumansNeoplasmsPhosphorylationSignal TransductionVirus ReplicationCapsid ProteinsCheckpoint Kinase 1Checkpoint Kinase 2CHEK1 protein, humanCHEK2 protein, humanVP3 protein, Chicken anemia virus

Identifiers

PMID27512067
PMCPMC5044837
OpenAlexW2499461011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.